Sarah Al-Hajali
Private Equity Investor bei Myrisoph Capital, Inc.
Profil
Sarah is an experienced C-suite executive with extensive regional experience in the GCC healthcare industry, having successfully lead a turnaround with attractive investor returns in her position as a CEO of the first private cord blood bank in the region in a JV with the largest European Stem Cell company.
Sarah is a Swedish-Romanian executive with a BSc in Chemical Engineering and a MSc in Biotechnology from Malardalens University in Sweden, as well as an MBA from the London Business School.
Aktive Positionen von Sarah Al-Hajali
| Unternehmen | Position | Beginn |
|---|---|---|
Myrisoph Capital, Inc.
 Myrisoph Capital, Inc. Investment ManagersFinance Myrisoph Capital, Inc. (Myrisoph Capital) is an independent private equity and venture capital firm founded in 2016. The firm is headquartered in Los Angeles, California. | Private Equity Investor | 01.12.2016 |
Ausbildung von Sarah Al-Hajali
| University of Stockholm | Graduate Degree |
| London Business School | Masters Business Admin |
| Mälardalen University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Myrisoph Capital, Inc.
Myrisoph Capital, Inc. Investment ManagersFinance Myrisoph Capital, Inc. (Myrisoph Capital) is an independent private equity and venture capital firm founded in 2016. The firm is headquartered in Los Angeles, California. | Finance |